Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

37.83
+0.21000.56%
Volume:205.52K
Turnover:7.80M
Market Cap:2.89B
PE:-12.58
High:38.55
Open:37.65
Low:37.45
Close:37.62
Loading ...

Xenon Pharmaceuticals Is Maintained at Buy by Goldman Sachs

Dow Jones
·
18 Apr

Xenon Pharmaceuticals to Present Promising Azetukalner Data at AAN 2025

TIPRANKS
·
04 Apr

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

GlobeNewswire
·
04 Apr

Analysts’ Top Healthcare Picks: Xenon (XENE), Janux Therapeutics Inc (JANX)

TIPRANKS
·
06 Mar

Strategic Growth Potential and Upcoming Catalysts Drive Buy Rating for Xenon Pharmaceuticals

TIPRANKS
·
01 Mar

RBC Capital Adjusts Xenon Pharmaceuticals Price Target to $58 From $56, Maintains Outperform - Speculative Risk Rating

MT Newswires Live
·
28 Feb

Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus

Zacks
·
28 Feb

Deutsche Bank Adjusts Xenon Pharmaceuticals Price Target to $60 From $67, Maintains Buy Rating

MT Newswires Live
·
28 Feb

Xenon Pharmaceuticals price target raised to $58 from $56 at RBC Capital

TIPRANKS
·
28 Feb

Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...

GuruFocus.com
·
28 Feb

Xenon Pharmaceuticals Q4 Net Loss Widens

MT Newswires Live
·
28 Feb

Xenon Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Earnings Flash (XENE) Xenon Pharmaceuticals Q4 Loss Per Share $-0.84 vs. FactSet Est Loss $-0.88

MT Newswires Live
·
28 Feb

Xenon Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Xenon Pharmaceuticals Q4 2024 GAAP EPS $(0.84) Beats $(0.86) Estimate

Benzinga
·
28 Feb

BRIEF-Xenon Pharmaceuticals Q4 Net Income USD -65.685 Million Vs. IBES Estimate USD -68.4 Million

Reuters
·
28 Feb

Xenon Pharmaceuticals to Present at TD Cowen Healthcare Conference

TIPRANKS
·
26 Feb

Xenon to Present at the 45th Annual TD Cowen Healthcare Conference

GlobeNewswire
·
26 Feb

Xenon Pharmaceuticals Price Target Maintained With a $53.00/Share by HC Wainwright & Co.

Dow Jones
·
24 Feb

Xenon Pharmaceuticals Inc : Deutsche Bank Initiates Coverage With Buy Rating; Price Target $67

THOMSON REUTERS
·
11 Feb